+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Plasma Protein Products Market - Global Forecast 2025-2030- Product Image
Plasma Protein Products Market - Global Forecast 2025-2030- Product Image
Sale

Plasma Protein Products Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126983
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Plasma protein products represent a cornerstone of modern biotherapeutic interventions, addressing critical clinical needs from immune support to hemostatic correction. Derived from human plasma through refined fractionation and purification protocols, these therapies have evolved significantly, driven by enhancements in manufacturing quality, regulatory oversight, and safety monitoring systems. Stakeholders now benefit from advanced chromatography and viral inactivation techniques, ensuring that albumin, coagulation factors, and immunoglobulins meet the highest efficacy and safety benchmarks in treating disorders such as immunodeficiencies, hemophilia, and hypoalbuminemia.

As patient populations grow and diversify, the market for plasma protein products has responded with innovations in subcutaneous immunoglobulin administration and recombinant factor technologies. Concurrently, biomanufacturers are contending with supply chain constraints related to donor plasma availability and cold chain logistics. Against this complex backdrop of clinical innovation and operational challenges, industry leaders must align strategic priorities-ranging from capacity expansion to regulatory compliance-to deliver life-saving therapies and sustain long-term growth.

Unveiling the Major Transformative Forces Disrupting Plasma Protein Products Market Landscape and Redefining Future Standards Across Therapeutic Applications

The plasma protein products industry is experiencing a convergence of technological breakthroughs and shifting therapeutic paradigms that are fundamentally reshaping market dynamics. Cutting-edge purification platforms that leverage continuous chromatography and membrane separation are accelerating production throughput while reducing contamination risks. In parallel, the rise of personalized medicine has prompted greater focus on precision dosing and patient-centric delivery systems, enabling more tailored treatment regimens for individuals requiring immunoglobulin maintenance or factor replacement.

Moreover, digital health solutions are emerging as a potent enabler of patient adherence and monitoring, particularly in home-based subcutaneous immunoglobulin therapies. The integration of real-time infusion pump telemetry and mobile health applications is empowering patients to manage chronic conditions more effectively, while generating invaluable usage data that inform pipeline prioritization for novel plasma-derived modalities. As these transformative shifts gain momentum, organizations are compelled to reexamine traditional business models, invest in advanced manufacturing infrastructure, and cultivate cross-functional partnerships that harness the full potential of a rapidly evolving landscape.

Assessing the Far-reaching Cumulative Impact of New United States Tariffs Announced for 2025 on Plasma Protein Product Supply Chains

In 2025, the imposition of new United States tariffs on imported plasma protein raw materials and finished therapies will exert a pronounced influence on cost structures throughout the value chain. Biomanufacturers may face elevated input expenses for key precursors, prompting renegotiation of long-term supplier agreements or the pursuit of alternate sourcing strategies. These tariff adjustments could also precipitate shifts in global supply routes, as companies explore partnerships with non-US suppliers to mitigate incremental duties, while maintaining critical reserves of albumin and immunoglobulin to ensure uninterrupted patient access.

Beyond direct cost implications, tariff-related uncertainties are likely to impact inventory management and forecasting accuracy. Organizations deploying just-in-time logistics may adopt more conservative stockholding policies to buffer against price volatility, potentially increasing warehousing and cold chain maintenance overhead. Regulatory liaisons will become indispensable as firms work to align customs classifications and valuation methodologies with evolving trade directives. Collectively, these factors underscore the need for proactive scenario planning and agile procurement frameworks to navigate the cumulative impact of the 2025 tariff landscape successfully.

Extracting Critical Insights from Key Segmentation Dimensions Illuminating Varied Dynamics in Plasma Protein Product Categories and Channels

A nuanced examination of segmentation reveals the interplay of product types, applications, distribution channels, and end users that define the plasma protein products market. The product type dimension encompasses albumin, coagulation factors, and immunoglobulins, with coagulation factors further delineated into Factor IX and Factor VIII therapies, and immunoglobulins subdivided into hyperimmune globulins, intravenous immunoglobulin, and subcutaneous immunoglobulin formulations. Each subset exhibits distinct production complexities, regulatory pathways, and therapeutic positioning, shaping manufacturer strategies for capacity allocation and pipeline innovation.

Application leads the market into diagnostic applications, research and development endeavors, and therapeutic interventions, each demanding specialized formulation characteristics and compliance protocols. Distribution channels span hospital pharmacy environments, online pharmacy platforms, and retail pharmacy touchpoints, reflecting an omnichannel approach that balances institutional procurement with patient self-administration models. The end user spectrum-including diagnostic laboratories, hospitals, research institutes, and specialty clinics-further informs product launch strategies, pricing frameworks, and stakeholder engagement plans. By integrating these four segmentation pillars, companies can craft targeted value propositions and optimize resource deployment across the entire plasma protein value chain.

Strategic Regional Variations and Growth Drivers Shaping the Plasma Protein Products Landscape Across Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics are pivotal in shaping the trajectory of plasma protein product adoption and supply chain optimization. In the Americas, robust healthcare infrastructure and established donor plasma networks have fostered a mature market environment, with sustained demand for albumin and immunoglobulin therapies driven by high per capita consumption and well-funded reimbursement frameworks. Shifts in regulatory harmonization with Canada and Mexico are streamlining cross-border trade, yet localized manufacturing capacity enhancements remain a strategic priority to reduce dependency on centralized fractionation facilities.

The Europe, Middle East & Africa region embodies a diverse array of regulatory regimes and market maturity levels. Western Europe’s stringent quality standards and centralized procurement models contrast with emerging Gulf Cooperation Council markets, where growing healthcare investment is catalyzing plasma collection center expansions. Africa’s fragmented infrastructure continues to present logistical challenges, yet targeted government initiatives are improving donor recruitment and cold chain capabilities. In the Asia-Pacific region, healthcare modernization programs in China, Japan, and Australia are stimulating demand for advanced immunoglobulin formulations, while rising chronic disease prevalence is accelerating market growth. Local partnerships and regional production hubs are becoming essential tactics for navigating tariff complexities and regulatory distinctiveness.

Profiling Leading Innovators and Key Strategic Initiatives Driving Competitive Advantage in the Plasma Protein Products Market

The competitive landscape of plasma protein products is characterized by a consortium of leading global biopharmaceutical firms and regional fractionators driving innovation and market expansion. A select group of multinational companies has invested heavily in state-of-the-art continuous production facilities, enabling scalable output of high-purity albumin and immunoglobulin therapies. These organizations frequently pursue mergers and strategic alliances to augment plasma collection capacities and broaden geographic reach, ensuring alignment with diverse regulatory requirements across key markets.

In parallel, mid-sized fractionators and specialized plasma centers are forging niche positions by focusing on hyperimmune globulin derivatives and subcutaneous immunoglobulin offerings. These players differentiate through agile R&D models, leveraging advanced analytics to optimize donor recruitment and enhance product yield. Collaborations with technology providers in bioprocess automation and digital supply chain management further reinforce their competitive stance. Collectively, these strategic initiatives underscore an industry-wide emphasis on operational excellence, product portfolio diversification, and sustained investment in next-generation plasma-derived therapies.

Actionable Strategic Recommendations Empowering Industry Leaders to Optimize Operations Navigate Challenges and Capitalize on Emerging Opportunities

Industry leaders should prioritize the expansion of diversified plasma collection networks to safeguard raw material supply and mitigate tariff-induced cost pressures. By establishing regional donor centers and leveraging mobile collection units, organizations can enhance supply resilience while responding to evolving regulatory guidelines. Concurrently, investments in continuous manufacturing technologies and digital cold chain monitoring systems will streamline operations, reduce waste, and strengthen quality assurance protocols.

To capitalize on emerging application segments, companies are advised to deploy advanced analytics for demand forecasting and patient adherence monitoring, particularly in home-based immunoglobulin therapies. Strategic collaborations with academic institutions and innovative technology partners can accelerate pipeline development in hyperimmune globulin derivatives and recombinant factor platforms. Furthermore, engaging proactively with trade regulators and policymakers will enable more effective navigation of tariff schedules, customs valuations, and compliance requirements. Together, these recommendations offer an actionable blueprint for sustaining competitive differentiation in a dynamic global landscape.

Comprehensive Research Methodology Combining Quantitative and Qualitative Approaches to Ensure Robust Insights and Validated Findings

This research employed a multi-stage methodology combining both quantitative and qualitative approaches to ensure robust insights and validated findings. Initially, a comprehensive review of secondary sources-including regulatory guidelines, industry white papers, and scientific publications-established the foundational context for plasma protein product classifications, emerging technologies, and regulatory shifts. Concurrently, proprietary databases were analyzed to map historical trends in plasma collection, manufacturing capacity, and global trade flows.

Subsequently, primary research was conducted through in-depth interviews with key opinion leaders, supply chain executives, regulatory affairs specialists, and healthcare providers across major regions. These interviews provided granular perspectives on operational challenges, tariff impacts, and innovation roadmaps. Data triangulation techniques were applied to reconcile findings from diverse sources, while internal peer reviews and validation workshops ensured methodological rigor. The resulting synthesis offers a balanced, evidence-based perspective tailored to inform strategic decision-making in the plasma protein products domain.

Concluding Insights Emphasizing the Strategic Imperatives and Future Outlook for Stakeholders in the Plasma Protein Products Ecosystem

This executive summary underscores the critical importance of adaptive strategies in the plasma protein products ecosystem. As regulatory landscapes evolve and tariff structures shift, companies must balance innovation in downstream therapeutic applications with upstream resilience in supply chain and plasma collection networks. Attention to segmentation dynamics-spanning product type, application, distribution channels, and end users-enables more precise alignment of development pipelines with market needs.

Looking ahead, the convergence of advanced manufacturing technologies, digital health integration, and strategic regional partnerships will define competitive leadership. Organizations that proactively diversify sourcing, optimize operational efficiencies, and foster collaborative alliances will be best positioned to deliver safe, effective therapies and capitalize on emerging value pools. By adhering to the actionable recommendations outlined herein, stakeholders across the value chain can navigate uncertainty with confidence and drive sustained growth in the plasma protein products market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Albumin
    • Coagulation Factors
      • Factor Iix
      • Factor Viii
    • Immunoglobulin
      • Hyperimmune Globulins
      • Ivig
      • Subcutaneous Immunoglobulin
  • Application
    • Diagnostics
    • Research And Development
    • Therapeutic
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Diagnostic Laboratories
    • Hospitals
    • Research Institutes
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Baxter International Inc.
  • Kedrion S.p.A.
  • Laboratoire Français du Fractionnement et des Biotechnologies
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • Sanquin Blood Supply Foundation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for monoclonal antibody therapies driving recombinant plasma protein development
5.2. Advancements in fractionation technologies improving yield and purity of plasma-derived immunoglobulins
5.3. Expansion of plasma collection networks through digital donor recruitment and retention platforms
5.4. Integration of pathogen inactivation processes ensuring safety of plasma derivatives in emerging economies
5.5. Regulatory harmonization across regions accelerating approvals for innovative plasma protein therapies
5.6. Growing adoption of subcutaneous immunoglobulin treatments enhancing at-home patient self-administration
5.7. Strategic partnerships between biotech companies and CMOs to scale up plasma protein manufacturing capacity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Plasma Protein Products Market, by Product Type
8.1. Introduction
8.2. Albumin
8.3. Coagulation Factors
8.3.1. Factor Iix
8.3.2. Factor Viii
8.4. Immunoglobulin
8.4.1. Hyperimmune Globulins
8.4.2. Ivig
8.4.3. Subcutaneous Immunoglobulin
9. Plasma Protein Products Market, by Application
9.1. Introduction
9.2. Diagnostics
9.3. Research and Development
9.4. Therapeutic
10. Plasma Protein Products Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Plasma Protein Products Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Research Institutes
11.5. Specialty Clinics
12. Americas Plasma Protein Products Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Plasma Protein Products Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Plasma Protein Products Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CSL Limited
15.3.2. Grifols, S.A.
15.3.3. Takeda Pharmaceutical Company Limited
15.3.4. Octapharma AG
15.3.5. Baxter International Inc.
15.3.6. Kedrion S.p.A.
15.3.7. Laboratoire Français du Fractionnement et des Biotechnologies
15.3.8. Bio Products Laboratory Ltd.
15.3.9. Biotest AG
15.3.10. Sanquin Blood Supply Foundation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PLASMA PROTEIN PRODUCTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PLASMA PROTEIN PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PLASMA PROTEIN PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PLASMA PROTEIN PRODUCTS MARKET: RESEARCHAI
FIGURE 24. PLASMA PROTEIN PRODUCTS MARKET: RESEARCHSTATISTICS
FIGURE 25. PLASMA PROTEIN PRODUCTS MARKET: RESEARCHCONTACTS
FIGURE 26. PLASMA PROTEIN PRODUCTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PLASMA PROTEIN PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY FACTOR IIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY FACTOR IIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IVIG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IVIG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 88. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 89. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 90. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 91. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 102. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 103. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 164. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 165. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 176. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 177. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 198. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 199. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 200. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 201. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 212. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 213. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 260. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 261. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 282. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 283. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 284. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 285. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 296. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 297. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN PLASMA PROTEIN PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA PLASMA PROTEIN PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. NI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Plasma Protein Products market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Baxter International Inc.
  • Kedrion S.p.A.
  • Laboratoire Français du Fractionnement et des Biotechnologies
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • Sanquin Blood Supply Foundation

Related Reports

Blood & Plasma Components Market - Global Forecast 2025-2030 - Product Image

Blood & Plasma Components Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Plasma Protein Therapeutics Market - Global Forecast 2025-2030 - Product Image

Plasma Protein Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Plasma Protein Therapeutics - Global Strategic Business Report - Product Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033 - Product Image

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Plasma Protein Therapeutics Market Report 2025 - Product Image

Plasma Protein Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.